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It has been recently shown that redox imbalance of luminal pyridine nucleotides in the endoplasmic reticulum (ER) together
with oxidative stress results in the activation of autophagy. In the present study we demonstrated that decrease of luminal
NADPH/NADP+ ratio alone by metyrapone was sufficient to promote the mechanism of “self-eating” detected by the activation
of LC3. Depletion of luminal NADPH had also significant effect on the key proteins of mTOR pathway, which got inactivated by
dephosphorylation. These findings were also confirmed by silencing the proteins (glucose-6-phosphate transporter and hexose-
6-phosphate dehydrogenase) responsible for NADPH generation in the ER lumen. However, silencing the key components and
addition of metyrapone had different effects on downstream substrates 4EBP1 and p70S6K of mTOR. The applied treatments did
not compromise the viability of the cells. Our data suggest that ER stress caused by luminal NADPH depletion activates a pro-
survival autophagic mechanism firmly coupled to the activation of mTOR pathway.
1. Introduction
The endoplasmic reticulum (ER) is a eukaryotic cellular
component that acts as an essential integrator of external and
internal stimuli by keeping the balance of protein level (so
called proteostasis) [1, 2]. ER has a crucial role in folding
and secretion of secreted and membrane proteins, calcium
storage, and lipid biosynthesis [2, 3]. Recent experimental
data have shown that for the proper function of the ER, a
high luminal NADPH/NADP+ ratio is essential [4, 5]. The
reduced luminal NADPH is required for the prereceptorial
activation of glucocorticoids (such as cortisol), for some
reactions of biotransformation and presumably for local
antioxidant defense. NADPH level is primarily sustained
by the coordinated action of the ER glucose-6-phosphate
transporter (G6PT) and the luminal hexose-6-phosphate
dehydrogenase (H6PDH), while NADPH can be consumed
by different luminal reductases (such as carbonyl reductases)
[6–8].
The imbalance of NADPH/NADP+ ratio or depletion of
luminal NADPH level sensitizes the ER to different oxidative
injuries [5]. Starvation has been reported to cause a shift
in the redox state of luminal pyridine nucleotides toward
the oxidized direction [9]. Experimentally, addition of G6PT
blockers S3483 or chlorogenic acid or the ROS generating
menadione results in the decrease of luminal NADPH [5,
10]. Metyrapone decreases luminal NADPH level by the
stimulation of carbonyl reductases and by carbonyl reductase
independent mechanisms [4, 11]. Interestingly, combined
treatment of NADPH depleting agents (e.g., inhibition or
silencing G6PT, silencing H6PDH, and oxidation of ER
luminal pyridine nucleotides) and oxidative stress induced by
menadione results in the induction of autophagymarkers [5].
It has been also proved that autophagosome formation
gets immediately induced in the presence of ER stressors
(such as thapsigargin and tunicamycin) [12, 13]. This obser-
vation is confirmed by increasing autophagic function. Any
disturbance of autophagy accelerates cell death claiming that
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autophagy plays important roles in cell survival during ER
stress [12, 13].
The autophagy plays an important role to “digest” the
damaged cytoplasmic components of cells at physiological
conditions [14]. In addition autophagy has an essential role in
promoting cellular-survival during starvation by “self-eating”
of parts of the cytoplasm and intracellular organelles [14, 15].
Autophagy induced by nutrient deprivation can bemimicked
by addition of drug rapamycin [16].
Mammalian target of rapamycin (mTOR) alias FKBP-
rapamycin associated protein (FRAP) is an evolutionally
conserved serine/threonine kinase of mTOR pathway that
is a major effector of cell growth and proliferation by
controlling protein synthesis [17, 18]. The phosphorylated
form of mTOR/FRAP is active, while the kinase becomes
immediately inactive and dephosphorylated upon nutrient
depletion [18]. Some of the targets of mTOR/FRAP are
phosphorylated directly, such as Eukaryotic translation ini-
tiation factor 4E-binding protein 1 (4EBP1) and Ribosomal
protein S6 kinase 1 (p70S6K). Both 4EBP1 and p70S6K
become dephosphorylated in response to starvation resulting
in block of protein translation [18, 19]. Some new results
have shown that DNA damage and ER stress-related Gadd34
is also required for autophagy induction under nutrient-
depleted conditions [20]. The Gadd34 knock-downed mice
cannot promote starvation-dependent mTOR/FRAP kinase
dephosphorylation [21]. However, beside CHOP/Gadd153,
Gadd34 is also a crucialmember of unfolded protein response
(UPR) [13]. UPR is a complex network of signalling pathways
measuring both the not properly folded protein level and
the precise balance between production and consumption of
folded proteins [13, 22].
In this study we reexamined the role of metyrapone
in autophagy induction claiming that NADPH depletion
without combination of oxidative agent can be sufficient
to enhance autophagic process. Treatment with NADPH
depleting agents results in dephosphorylation of the key
molecules of mTOR pathway confirming that the imbalance
of ER luminal pyridine nucleotides induces a starvation
phenotype.
2. Materials and Methods
2.1. Materials. Metyrapone, rapamycin, 3-methyladenine,
Wortmannin, and trypan blue were purchased from Sigma.
All other chemicals were of reagent grade.
2.2. Cell Culture and Maintenance. As model system, human
liver carcinoma (HepG2) cell line was used. Due to the
relatively large dimension of ER in HepG2 cells they offer
an excellently suitable in vitromodel system for studying the
effect of addition of different type of ER stressors. HepG2 cells
were maintained in DMEMmedium supplemented with 10%
fetal bovine serum and 1% antibiotics/antimycotics. Culture
dishes and cell treatment plates were kept in a humidified
incubator at 37∘C in 95% air and 5% CO
2
.
2.3. RNA Interference. The silencing of G6PT and H6PDH
was managed by transfection with siG6PT and/or siH6PDH,
respectively. The corresponding RNA interference was per-
formed using Lipofectamine RNAi Max (Invitrogen) in
GIBCOTMOpti-MEM I (GlutaMAXTM-I) Reduced-Serum
Medium liquid (Invitrogen) and 20 pmol/mL siRNA. Inter-
fering RNAs for human G6PT (gene ID: NM 001467) and
H6PD were constructed by Invitrogen. The used oligonu-
cleotide for human G6PT: 5󸀠-CGAAACAUCCGCACC-
AAGAdTdT-3󸀠 (sense) and 5󸀠-UCUUGGUGCGGAUGU-
UUCGdTdT-3󸀠 (antisense) [23].Theused oligonucleotide for
human H6PD was 5󸀠-UUAUGGAGACAUGUCCCUGGA-
GCUC-3󸀠 (sense) and 5󸀠-GAGCUCAGGGACAUGUCU-
CCAUAA-3󸀠 (antisense). Interferingmaterials were annealed
duplexes in both cases [5].
2.4. SDS-PAGE and Western Blot Analysis. HepG2 cells were
harvested and lysed with 20mM Tris, 135mM NaCl, 10%
glycerol, and 1% NP40 at pH 6.8. Protein content of cell
lysates was measured using Pierce BCA Protein Assay. Equal
amounts of protein were used in each procedure. SDS-PAGE
was performed by using Hoefer miniVE (Amersham). The
protein patterns were transferred onto Millipore 0.45𝜇m
PVDF membrane. Immunoblotting was accomplished with
TBS Tween (0.1%), containing 5% nonfat dry milk for
blocking membrane and for antibody solutions. The cor-
rect loading was controlled by staining with Ponceau S
in each experiment. The following antibodies were used:
antiGADD153, antiLC3B, antiGADD34, antimTOR/FRAP,
antimTOR/FRAP-P, antip70S6K, antip70S6K-P, antiprocas-
pase 3, antiGAPDH (SantaCruz), anti4EBP1, anti4EBP1-P,
antiPARP, antieIF2alpha-P, antieIF2alpha (Cell Signaling),
and HRP conjugated secondary antibodies (SantaCruz).
2.5. Cell Viability Assays. The number of viable cells was
detected using a trypan blue exclusion assay. Cells were
incubatedwith isotonic solution of trypan blue 0.6% and both
permeabilized and nonpermeabilized cells were counted.
In case of each experiment at least three parallels were
measured. Cell viability was also determined by CellTiter-
Blue Assay from Promega. 20 𝜇L of reagent was added to
each 100 𝜇L of medium in a 96-well plate. In this method
the viable cells are able to reduce the indicator dye resazurin
into resorufin, while the nonviable cells lose their metabolic
capacity.The absorbance was read at 570 nm using 600 nm as
a reference wavelength.
2.6. HPLC Detection of Metyrapone. The uptake of drug
metyrapone was measured via HPLC. Cell cultures were
incubated for 0, 10, 20, 30, 40, and 120min, then cells and
media were separated, and cells were lysed with 20mM Tris,
135mM NaCl, 10% glycerol, and 1% NP40 at pH 6.8. 150𝜇L
media of each sample was directly added to 150 𝜇L ice-cold
methanol. The protein concentration of each sample was set
to 0.075mg/mL with MOPS buffer. Then 150𝜇L of these
samples were added to 150 𝜇L ice-cold methanol. Samples
were stored at −20∘C until analysis. After sedimentation
of the precipitates by centrifugation (20 000×g for 10 min
at 4∘C), the metyrapone content of the supernatants was
measured by HPLC (Alliance 2690; Waters Corp., Milford,
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MA,USA) using aNucleosil 100 C18 column (5 𝜇m25× 0.46)
(Teknokroma). The eluent was 58% methanol, samples were
eluted for 30 min and the absorbance was detected at 245 nm
wavelength (Dual l AbsorbanceDetector 2487).The retention
times of metyrapone (approx. 15min) was determined by
injecting standards.
3. Results
3.1. NADPH Depletion in the ER Lumen by Metyrapone
Results inAutophagyActivation andDownregulation ofmTOR
Pathway. We have shown previously that combination of
depletion of ER luminal NADPH and menadione-induced
oxidative stress injury results in autophagy and decreased
viability in HepG2 cells [5]. However, under experimental
conditions performed in those experiments imbalance of
NADPH level caused by metyrapone alone was not sufficient
to induce autophagic events or viability alterations. Here we
found that prolonged incubation was not sufficient to induce
autophagy (data not shown), but the increased concentration
of metyrapone (75–100 𝜇M) was able to promote formation
of autophagy marker, LC3II; however, the apoptosis markers,
such as cleavage of PARP and procaspase 3, did not show any
apoptotic event suggesting that an autophagy-dependent pro-
cess switches on during metyrapone treatment (Figure 1(a)).
To investigate further the general effect of luminal
NADPH depletion, a viability assay was carried out and
the viable cells were also counted (Figures 1(b) and 1(c)).
These analyses showed—in accordance with previous find-
ings [5]—that no cumulative cell death was present dur-
ing the treatment at either metyrapone concentration for
1 hour (Figures 1(b) and 1(c)). These results suggest that
high concentration of metyrapone results in drug-induced
autophagy; however, this mechanism does not enhance “self-
eating”-dependent cell death. To confirm the positive effect of
metyrapone on autophagy induction a combined treatment
was established with various autophagy inhibitors, such as 3-
methyladenine and Wortmannin (Figure 2). Autophagy was
less evident in both simultaneous treatments (metyrapone +
3-methyladenine and metyrapone + Wortmannin) and rela-
tive cell viability was also decreased (Figure 2). Cleaved PARP
indicates apoptotic cell death at addition ofWortmannin even
at combined treatment. Thus, NADPH depletion-induced
autophagy showed similar characteristic to rapamycin treat-
ment (Figure 2).
Beside autophagy activation, a remarkable induction of
Gadd34 and the slight but delayed activation of proapoptotic
CHOP/Gadd153 could also be observed upon metyrapone
addition (at concentrations >50 𝜇M) confirming ER stress
(Figure 3(a)). eIF2𝛼 phosphorylation could not be observed
after 1-hour treatment in accordance with the phosphatase
activity of induced Gadd34 (Figure 3(a)).
As Gadd34 acts on mTOR/FRAP pathway negatively
by dephosphorylating and activates the inhibitor TSC2 of
mTOR/FRAP directly [20] we are interested in whether
this starvation-controlled pathway is active or not during
metyrapone treatment. Therefore, the phosphorylation of
mTOR/FRAP kinase and its two well-known downstream
targets (4EBP1 and p70S6K) was also followed by Western
blotting (Figure 3(b)). Although Gadd34 gets activated and
mTOR/FRAP becomes dephosphorylated at drug concentra-
tion >50 𝜇M, 4EBP1 is not shown any dephosphorylation
after 1- hour treatment. These data suggest that mTOR path-
way could not be fully inactived during redox imbalance
of ER luminal pyridine nucleotides. Interestingly p70S6K
kinase, the other target of mTOR/FRAP becomes almost
completely dephosphorylated even after 1 hour treatment
with 10 𝜇M metyrapone (Figure 3(b)) supposing that drug-
induced luminal NADPH depletion of ER has actually some
negative effect on mTOR/FRAP-dependent starvation path-
way.
3.2. The kinetic Profile of Metyrapone-Induced mTOR Inac-
tivation. To get the time course of metyrapone treatment
(100 𝜇M), its effects were followed in time. The level of
LC3II was already elevated at 1 h and further increased
at 2 h of incubation with 100 𝜇M metyrapone assuming
autophagic process after 1-hour treatment (Figure 4(a)).
Interestingly eIF2𝛼 phosphorylation and activity of both
Gadd34 and CHOP/Gadd153 show only a transient peak
(Figure 4(b)). Metyrapone treatment resulted in a stress-
dependent UPR activation; however, the UPR elements
completely disappeared after 120min. These data also sup-
port the idea that autophagy activated by NADPH deple-
tion promotes a cell survival process by adapting the
cells to a tolerable stress condition. We claim that the
metyrapone-induced ER stress is not severe enough to induce
cell death. No PARP cleavage was observed during treat-
ment supposing that apoptotic process remained inactive
(Figure 4(a)). These results were also confirmed by carry-
ing a viability assay, which did not show any cumulative
cell death even after 2-hour long luminal redox imbalance
(Figure 4(c)).
The time course of the phosphorylation of the key com-
ponents of mTOR pathway was also examined. mTOR/FRAP
gets dephosphorylated after 50–60min, and this dephos-
phorylation became completed after 2 hours supposing
the turning off of mTOR/FRAP pathway during treatment
(Figure 5). While mTOR/FRAP getS dephosphorylated rel-
atively late, the inactivation of p70S6K was observed after
15min. Although both mTOR/FRAP and p70S6K kinase
get dephosphorylated, mTOR/FRAP target 4EBP1 remains
active and phosphorylated (Figure 5). This various activa-
tion profile of downstream targets of mTOR/FRAP suggests
kinetic differences between them. It can also be possible that
metyrapone treatment has an mTOR-independent effect on
4EBP1 and/or p70S6K phosphorylation/dephosphorylation.
To rule out the possibility that cells are able to adapt
to metyrapone by pumping the drug out, its uptake was
measured by HPLC. The increase of metyrapone concentra-
tion in the cells shows hyperbolic characteristic reaching a
maximum level after 30min and it was maintained on this
level even after 120min (Figures 6(a) and 6(b)). This picture
shows that a constant metyrapone level was reached after
30min in the cell, which was in agreement with the time
course of metyrapone induced effects.
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Figure 1: NADPH depletion induced by metyrapone is sufficient to promote autophagy. HepG2 cells were treated with different amount
of metyrapone (10 𝜇M–100 𝜇M) for 1 h at 37∘C. (a) Cell lysates were analysed by Western blot by immunoreacting with antibodies against
LC3, procaspase 3, PARP, and GAPDH, respectively. The relative density of both the lower band of LC3/GAPDH and PARP/GAPDH were
plotted. (b) Cell viability was assessed by counting the cells both permeable and nonpermeable for trypan blue. About 95% of the cells were
nonpermeable for trypan blue. (c) Cell viability was followed by using Cell Titer-Blue Assay and the relative cell viability was represented after
1-hour longmetyrapone treatment. As positive controls cells were treated with tunicamycin (TM—25 𝜇M) for 2 hours combinedwith/without
2-hour long 3-methyladenine pretreatment (3-MA—10mM).
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Figure 2: NADPH depletion and autophagy inhibition together promote cell death. HepG2 cells were treated with metyrapone (Mety—
100𝜇M), rapamycin (Rap—100 nM), Wortmannin (Wort—1 𝜇M), and 3-methyladenine (3-MA—10mM) for 2 h at 37∘C. Cells were also
pretreated with Wort/3-MA for 2 h; then Mety/Rap was added for another 2 h. (a) Cell lysates were analysed by Western blot by
immunoreacting with antibodies against LC3, PARP, and GAPDH, respectively. (b) Cell viability was followed by using Cell Titer-Blue Assay
and the relative cell viability was represented after treatment.
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Figure 3: NADPH depletion induced by metyrapone enhances ER stress and influences the phosphorylation status of mTOR pathway
proteins. HepG2 cells were treated with different amount of metyrapone (10 𝜇M–100𝜇M) for 1 h at 37∘C. (a) Cell lysates were analysed
by Western blot by immunoreacting with antibodies against eIF2𝛼-P, eIF2𝛼, CHOP/Gadd153, GAPDH, and Gadd34, respectively. The
relative density of Gadd34/GAPDH was plotted. (b) Cell lysates were analysed by Western blot by immunoreacting with antibodies against
mTOR/FRAP-P, mTOR/FRAP, 4EBP1-P, 4EBP1, p70S6K-P, and p70S6K, respectively. The relative density of phosphorylated FRAP/GAPDH
was represented.
3.3. Imbalance of ER Luminal NADPH/NADP+ Ratio and
mTOR Inactivation by Silencing of G6PT and/or H6PDH.
Although the role of metyrapone was already proved by
imbalance the pyridine nucleotide level in luminal ER, the
exact way of its action, and its targets have been not explored
yet. We had to confirm that metyrapone is not able to act
directly on one of the steps of mTOR pathway besides induc-
ing the depletion of ER luminal NADPH. Therefore, the two
key proteins of maintaining luminal NADPH level, G6PT,
and H6PDH were silenced in HepG2 cells by transfection
with the corresponding siRNA. G6PT is needed for glucose-
6-phosphate uptake of the ER, while H6PDH transforms
glucose-6-phosphate to 6-phosphogluconate by generating
NADPH [24]. This transformation requires NADP+; there-
fore, silencing the expression of these two genes results in
serious NADPH depletion in the ER lumen.
Transfection of HepG2 cells with siG6PT and/or
siH6PDH reduced the level of G6PT and/or H6PDH
dramatically (Figure 7). Both siG6PT and siH6PDH resulted
in activation of autophagic event (Figure 7). This was
demonstrated by the remarkable increase of LC3II level
and intensive Gadd34 expression, while the cleavage of
procaspase 3 and PARP was not observed. These data
show that similarly to autophagy induced by metyrapone
treatment, the survival process switches on during silencing
of G6PT and/or H6PDH. Interestingly, the mTOR/FRAP
target 4EBP1 gets fully dephosphorylated after silencing
G6PT and/or H6PDH suggesting that imbalance of luminal
NADPH/NADP+ ratio affects the mTOR/FRAP pathway
negatively (Figure 7). Silencing of either G6PT or H6PDH, in
agreement with our previous results [5], did not compromise
the viability of the cells (data not shown).
4. Discussion
The present results show that depletion of ER NADPH either
by the pharmacological agent metyrapone or by silencing of
the key proteins of luminal NADPH generation switched on
an autophagic mechanism with the incomplete inactivation
of the mTOR pathway.
We observed that high concentration of metyrapone was
able to enhance the autophagy marker LC3II even after
1 h, suggesting that the imbalance of ER luminal pyridine
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Figure 4: Time course of the effect of high concentration metyrapone on ER stress. HepG2 cells were treated with 100 𝜇M metyrapone
for 5–120min at 37∘C. (a) Cell lysates were analysed by Western blot by immunoreacting with antibodies against LC3, PARP, and GAPDH,
respectively.The relative density of both the lower band of LC3/GAPDH and PARP/GAPDHwere represented. (b) Cell lysates were analysed
by Western blot by immunoreacting with antibodies against ER stress markers, such as eIF2𝛼-P, eIF2𝛼, CHOP/Gadd153, and Gadd34,
respectively. The relative density of Gadd34/GAPDH was represented. (c) Cell viability was assessed by counting the cells both permeable
and non-permeable to trypan blue. About 5% of the cells were nonpermeable for trypan blue.
nucleotides is alone sufficient to induce the “self-eating”
mechanism (Figure 1). The ER-stress related autophagy
inducer Gadd34 became active at relatively low concentra-
tion of metyrapone, while increased expression of the pro-
apoptotic transcription factor CHOP/Gadd153 was detected
only at high amount of drug (Figure 3(a)). Since this induc-
tion of CHOP/Gadd153 did not result in a decrease of cell
viability in our experimental system (Figure 1), we suggested
that autophagic response induced by NADPH depletion
might have a role in cell survival. This observation was
also confirmed by using autophagy inhibitors together with
metyrapone (Figure 2). Interestingly, metyrapone after a
short exposure (30min) transiently increased the expression
of transcription factor CHOP/Gadd153 following Gadd34
induction (Figure 4(b)), but cells remained viable (Figures
4(a) and 4(c)). These results suggest that first autophagy
gets activated to turn on the “self-eating” mechanism to heal
damages. Later apoptosis via CHOP tries to switch on but
the stress level induced by NAPDH depletion is not high
enough to develop the self-killing mechanism; therefore,
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Figure 5: Time course of the effect of high concentrationmetyrapone on phosphorylation status ofmTORpathway proteins.HepG2 cells were
treatedwith 100 𝜇Mmetyrapone for 5–120min at 37∘C. Each sample was analysed byWestern blot by immunoreacting with antibodies against
mTOR/FRAP-P, mTOR/FRAP, 4EBP1-P, 4EBP1, p70S6K-P, and p70S6K, respectively. The relative density of phosphorylated FRAP/GAPDH
was represented. As positive control of autophagy cells were treated with 100 nM rapamycin for 1 hour at 37∘C.
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Figure 6: Metyrapone uptake of HepG2 cells. HepG2 cells were treated with 100 𝜇Mmetyrapone for 0–120min at 37∘C. (a) After cell lysis,
cells metyrapone concentrations were measured by HPLC till 120min upon the addition of metyrapone, and their relative amounts were
calculated both in the media (black diamond) and the cells (black triangle). (b) Metyrapone concentration in cells referring to cell volume is
plotted at each time point and a trend line was fitted (black hyperbolic line). For detailed description of HPLC method see Section 2.
CHOP/Gadd153 has only a transient peak. These results
correspond to our recently published data where we claim
that cellular stress induces autophagy-dependent survival
immediately, while the stress level has to reach a critical
threshold to promote apoptotic cell death [25].
Gadd34 has been shown to induce autophagy via the
dephosphorylation of TSC2, which leads to the suppression
of themTORpathway, a potent inhibitor of autophagy [21]. In
agreementwith the supposed role ofGadd34 in the regulation
of mTOR pathway, a decreased phosphorylation of mTOR
and p70S6K was also observed after longer incubations.
However, the mTOR target 4EBP1 remains phosphorylated
(Figure 5). This various activation profile of downstream
targets of mTOR suggests kinetic differences between them.
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Figure 7: Transient knockdown of G6PT and/or H6PDH by siRNAs induces autophagy. HepG2 cells were treated with siRNA construct for
G6PT and/or H6PDH. For description of this method see Section 2. Cells were lysed after 24 hours of silencing and samples were analysed
by Western blot by immunoreacting with antibodies against G6PT, H6PDH, GAPDH, LC3, procaspase 3, PARP, Gadd34, mTOR/FRAP-P,
mTOR/FRAP, 4EBP1-P, 4EBP1, p70S6K-P and p70S6K, respectively.
It can also be possible that metyrapone treatment has an
mTOR-independent effect on 4EBP1 and/or p70S6K phos-
phorylation/dephosphorylation. These considerations are
also supported by the observations that p70S6K dephos-
phorylation precedes that of mTOR (Figure 5) and requires
lower metyrapone concentration (Figure 3(b)). Moreover,
4EBP1 dephosphorylation was evident upon silencing-based
consumption of the luminal NADPH pool (Figure 7). It
should be noted that although the downstream targets of
mTOR (i.e., p70S6K and 4EBP1) are supposed to be regulated
in line with each other, in some cases they are inhibited
differently [26, 27].
The results gained by metyrapone were confirmed by
silencing of the proteins responsible for generation ER lumi-
nal NADPH. Activation of the autophagic machinery was
indicated by increased Gadd34 expression, LC3II formation,
and dephosphorylation of 4EBP1 (Figure 7).
In conclusion, the depletion of luminal NADPH in the
ER (and/or the decreased NADPH/NADP+ ratio) results
in ER stress followed by the activation of autophagic
response. The scenario consists of the temporary increase of
CHOP/Gadd153 without the alteration of cell viability. Thus,
the NADPH depletion dependent ER stress unequivocally
results in a physiological prosurvival response. Although the
elements of mTOR pathway respond differently to imbalance
of luminal pyridine nucleotides, these data suggested that the
NADPH depletion-induced autophagosome formation has
starvation-related phenotype.The findings underline the role
of the redox state of ER luminal pyridine nucleotides (and the
metabolic pathways affecting it) in the nutrient sensing of the
cell [24].
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